Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT00061932Phase 2Completed
Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach
Adenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+5 more
Principalinvestigator
NCT00075504Phase 2Completed
Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer
Stage II Gallbladder CancerStage IIIA Gallbladder CancerStage IIIB Gallbladder Cancer+2 more
Principalinvestigator
NCT00100841Phase 2Completed
Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer
Adenocarcinoma of the RectumMucinous Adenocarcinoma of the ColonRecurrent Colon Cancer+4 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Hedy Kindler

University of Chicago Comprehensive Cancer Center

Related
6 trials

Shared therapeutic areas:

Diffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the StomachMixed Adenocarcinoma of the Stomach+9 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score18%

Lakshmi Rajdev

ECOG-ACRIN Cancer Research Group

Related
4 trials

Shared therapeutic areas:

Adenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Adenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Stephen Michael Hahn

Abramson Cancer Center at Penn Medicine

Related
6 trials

Shared therapeutic areas:

Recurrent Colon CancerRecurrent Gastric CancerRecurrent Rectal Cancer+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Vincent Chung, MD

City of Hope Medical Center

Related
6 trials

Shared therapeutic areas:

Recurrent Colon CancerRecurrent Gastric CancerRecurrent Rectal Cancer+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Betty Ferrell

City of Hope Medical Center

Related
5 trials

Shared therapeutic areas:

Recurrent Colon CancerRecurrent Gastric CancerRecurrent Rectal Cancer+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Heinz-Josef Lenz

University of Southern California

Related
4 trials

Shared therapeutic areas:

Recurrent Colon CancerRecurrent Rectal CancerStage IV Colon Cancer+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Jean L Grem, MD

University of Nebraska

Related
4 trials

Shared therapeutic areas:

Adenocarcinoma of the Gastroesophageal JunctionStage IIIA Gallbladder CancerStage IIIB Gallbladder Cancer+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Manish Sharma

University of Chicago Comprehensive Cancer Center

Related
4 trials

Shared therapeutic areas:

Stage IIIA Gallbladder CancerStage IIIB Gallbladder CancerStage IIIB Gastric Cancer+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Caio Rocha Lima, MD

Wake Forest University Health Sciences

Related
4 trials

Shared therapeutic areas:

Mucinous Adenocarcinoma of the ColonRecurrent Colon CancerRecurrent Rectal Cancer+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00061932Phase 2PrincipalInvestigator

Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach

Adenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+5 more
Completed
NCT00075504Phase 2PrincipalInvestigator

Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer

Stage II Gallbladder CancerStage IIIA Gallbladder CancerStage IIIB Gallbladder Cancer+2 more
Completed
NCT00100841Phase 2PrincipalInvestigator

Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer

Adenocarcinoma of the RectumMucinous Adenocarcinoma of the ColonRecurrent Colon Cancer+4 more
Completed

All 3 trials loaded